CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis

Braun M, Qorraj M, Büttner M, Klein FA, Saul D, Aigner M, Huber W, Mackensen A, Jitschin R, Mougiakakos D (2016)

Publication Type: Journal article

Publication year: 2016

Journal

Leukemia Springer Nature

Book Volume: 30

Pages Range: 1788-92

Journal Issue: 8

DOI: 10.1038/leu.2016.58

Authors with CRIS profile

Michael Braun Department of Ophthalmology Andreas Mackensen Lehrstuhl für Innere Medizin V Dimitrios Mougiakakos Professur für CAR-T-Zell-Therapie

Involved external institutions

European Molecular Biology Laboratory (EMBL) DE Germany (DE)

How to cite

APA:

Braun, M., Qorraj, M., Büttner, M., Klein, F.A., Saul, D., Aigner, M.,... Mougiakakos, D. (2016). CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis. Leukemia, 30(8), 1788-92. https://doi.org/10.1038/leu.2016.58

MLA:

Braun, Michael, et al. "CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis." Leukemia 30.8 (2016): 1788-92.

BibTeX: Download